Edition:
United Kingdom

Kitov Pharmaceuticals Holdings Ltd (KTOV.OQ)

KTOV.OQ on NASDAQ Stock Exchange Capital Market

2.31USD
15 Dec 2017
Change (% chg)

$0.17 (+7.94%)
Prev Close
$2.14
Open
$2.18
Day's High
$2.33
Day's Low
$2.18
Volume
24,288
Avg. Vol
68,056
52-wk High
$3.49
52-wk Low
$1.27

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 --
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Year Ending Dec-17 1 0.00 0.00 0.00 4.02
Year Ending Dec-18 1 7.34 7.34 7.34 14.07
Earnings (per share)
Quarter Ending Dec-17 1 -0.01 -0.01 -0.01 --
Quarter Ending Mar-18 1 -0.01 -0.01 -0.01 --
Year Ending Dec-17 1 -0.05 -0.05 -0.05 -0.40
Year Ending Dec-18 1 -0.01 -0.01 -0.01 0.18
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.76 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) -- 100.68 5.40
Price to Book (MRQ) -- 13.50 5.38
Price to Tangible Book (MRQ) -- 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions -- 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 433.86 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 75.04 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) -- 5.36 2.98
LT Debt to Equity (MRQ) -- 18.92 11.56
Total Debt to Equity (MRQ) -- 20.59 15.81
Interest Coverage (TTM) -- -112.21 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -261.12 15.24
Operating Margin (TTM) -- -556.66 7.76
Operating Margin - 5 Yr. Avg. -- -279.30 10.75
Pre-Tax Margin (TTM) -- -529.90 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.03 11.17
Net Profit Margin (TTM) -- -531.35 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.21 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 25,315,636 864,680,397
Net Income/Employee (TTM) -- 3,332,197 101,718,341
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) -- 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.77 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -- 2.36 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -- 2.96 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51

Performance for Kitov Pharmaceuticals Holdings Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.14%
# of Holders: 5
Total Shares Held: 128,175
3 Mo. Net Change: -81,822
# New Positions: 2
# Closed Positions: 4
# Increased Positions: 2
# Reduced Positions: 7
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.